Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for central nervous system agents and antidepressants. Its structure supports the formation of biologically active molecules due to the presence of both primary amine groups and the electron-withdrawing trifluoromethyl group, which enhances metabolic stability and bioavailability. Also employed in the preparation of agrochemicals and specialty polymers where fluorinated aromatic amines improve material performance. Commonly utilized in research settings for designing novel compounds with targeted biological activity.